5658-70-8

Basic information

• Product Name: 2-(4-bromophenoxy)-2-methylpropanamide
• CAS NO: 5658-70-8
• Molecular Formula: C₁₀H₁₂BrNO₂
• Molecular Weight: 258.1118
• Mol File: 5658-70-8.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 393.6°C at 760 mmHg
• Flash Point: 191.8°C
• Density: 1.434g/cm³
• Vapor Pressure: 2.11E-06mmHg at 25°C
• Refractive Index: 1.558
• CAS DataBase Reference: 2-(4-bromophenoxy)-2-methylpropanamide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-bromophenoxy)-2-methylpropanamide(5658-70-8)
• EPA Substance Registry System: 2-(4-bromophenoxy)-2-methylpropanamide(5658-70-8)

Safety Data

• Hazardous Substances Data: 5658-70-8(Hazardous Substances Data)

Usage

Type of compound

Carbamate derivative

Substituents

Bromophenoxy group, methylpropanamide moiety

Potential uses

Pharmaceutical and agricultural applications

Chemical structure significance

Valuable building block for the synthesis of other organic compounds

Possible biological activity

Of interest for research and development purposes

Further study implications

Could lead to new uses and benefits for this chemical

Upstream product

• 106-41-2 4-bromo-phenol 
• 7462-74-0 2-bromo-2-methylpropanamide 
• 7472-69-7 2-(4-bromophenoxy)-2-methylpropanoic acid 

Downstream Products

• 1082589-18-1 2-(4-bromophenoxy)-2-methylpropan-1-amine 
• 1610667-20-3 tert-butyl (2-(4-bromophenoxy)-2-methylpropyl)carbamate 
• 1610667-19-0 tert-butyl(2-methyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)propyl)carbamate 
• 124188-25-6 2-(4-bromo-2-nitrophenoxy)-2-methylpropanamide 
• 124188-35-8 8-bromo-2,2-dimethyl-8-nitro-1-oxa-4-azaspiro<4.5>-deca-6,9-dien-3-one 

Relevant articles and documents

COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES

The present invention provides compounds of formula I: [INSERT FORMULA HERE] or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease, such as malaria, caused by a Plasmodium parasite.